tasadenoturev

AXP000005.1 · Oncolytic virus

Platform
adenovirus (Ad5 Delta-24-RGD)
Originator
The University of Texas MD Anderson Cancer Center
Sponsor
DNAtrix

Names

NameTypeSource
tasadenoturevpreferred name, INNcurator, ncit
Ad5-Delta24RGDcodencit
DNX-2401codencit
Ad5-d24-RGDsynonympaper
Delta-24-RGD ambiguousformer codepress

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus 5 (NCBI Taxonomy 28285)
Strain
Ad5 Delta-24-RGD
Replication
conditionally replicating
Modifications
24-bp deletion in E1A CR2; RGD-4C motif in fiber HI loop
Route
intratumoral, intracerebral
Carrier
mesenchymal stem cells (in some studies)
Source
evidence

Cross-references

NCI Thesaurus
C74067
FDA UNII
79ME7DT193

Approvals

No regulatory approval recorded.

Clinical trials (10)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT07444606Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial MetastasesRecruitingPhase 12026-09-252027-01-3050Melanoma
NCT07424092Intratumoral DNX-2401 for High Grade Pediatric Brain TumorsRecruitingPhase 22026-05-122029-0539Embryonal Tumor of Brain; Ependymoma; High Grade Glioma; Pediatric; Recurrence; Refractory; Young Adult
NCT05009992Combination Therapy for the Treatment of Diffuse Midline GliomasRecruitingPhase 22021-10-202027-12-31360Diffuse Intrinsic Pontine Glioma; Diffuse Midline Glioma, H3 K27M-Mutant; Recurrent Diffuse Intrinsic Pontine Glioma; Recurrent Diffuse Midline Glioma, H3 K27M-Mutant; Recurrent WHO Grade III Glioma; WHO Grade III Glioma
NCT03896568MSC-DNX-2401 in Treating Patients With Recurrent High-Grade GliomaRecruitingPhase 12019-02-122027-09-3036IDH1 wt Allele; Recurrent Anaplastic Astrocytoma; Recurrent Glioblastoma; Recurrent Gliosarcoma; Recurrent Malignant Glioma
NCT03178032Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine GliomasCompletedPhase 12017-05-262021-01-3112Brainstem Glioma; Neoadjuvant Therapy
NCT02798406Combination Adenovirus + Pembrolizumab to Trigger Immune Virus EffectsCompletedPhase 22016-10-062021-03-1749Brain Cancer; Brain Neoplasm; Glioblastoma; Glioma; Gliosarcoma; Malignant Brain Tumor; Neoplasm by Histologic Type; Neoplasm, Nerve Tissue; Neoplasm, Neuroepithelial; Nervous System Diseases; Neuroectodermal Tumors
NCT02197169DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain TumorsCompletedPhase 12014-09-112018-03-1537Glioblastoma or Gliosarcoma
NCT01956734Virus DNX2401 and Temozolomide in Recurrent GlioblastomaCompletedPhase 12013-092015-1231Glioblastoma Multiforme; Recurrent Tumor
NCT00805376DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant GliomasCompletedPhase 12009-022015-0237Brain Cancer; Central Nervous System Diseases
NCT00562003Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer PatientsCompletedPhase 12007-062009-0526Ovarian Cancer; Primary Peritoneal Cancer
Unconfirmed matches (1)

Trials that mention one of the names in a weaker way (a code only in the title, a short or ambiguous name). Not counted above.

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditionsMatched by
NCT01582516Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent GlioblastomaCompletedPhase 1/22010-062014-1220Brain Tumor; Recurring Glioblastomaname in intervention: Delta-24-RGD

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 37925150Magnetic Resonance Imaging-Aided SmartFlow Convection Delivery of DNX-2401: A Pilot, Prospective Case Series.World neurosurgery2024name in title: DNX-2401
PMID 38311852Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice.Molecular therapy : the journal of the American Society of Gene Therapy2024cited by trial NCT00805376
PMID 37188783Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.Nature medicine2023cited by trial NCT02798406
PMID 37195023ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.Cancer research2023cited by trial NCT05009992
PMID 34824133Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of malignant brain tumors.Journal of neurointerventional surgery2022cited by trial NCT03896568
PMID 35157764Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas.Neuro-oncology2022cited by trial NCT05009992
PMID 35767439Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.The New England journal of medicine2022cited by trial NCT03178032
PMID 31138805The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models.Nature communications2019cited by trial NCT03178032
PMID 29088386Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients.Neurosurgery2018name in title: DNX-2401
PMID 29432077Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology2018cited by trial NCT00805376
PMID 29594041DNX-2401, an Oncolytic Virus, for the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Gliomas: A Case Report.Frontiers in oncology2018name in title: DNX-2401
PMID 24903904Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria.Neuro-oncology2015cited by trial NCT03178032
PMID 21630267Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.International journal of cancer2012name in title: Ad5-d24-RGD
PMID 17848677Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death.Journal of the National Cancer Institute2007cited by trial NCT03178032
PMID 18089777Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter.Cancer research2007cited by trial NCT03178032
Unconfirmed matches (2)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 41609523Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET).Clinical cancer research : an official journal of the American Association for Cancer Research2026name in title: Delta-24-RGD
PMID 35176144Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies.Clinical cancer research : an official journal of the American Association for Cancer Research2022name in title: Delta-24-RGD

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 41325798Oncolytic virotherapy: Molecular mechanisms, delivery strategies, and translational insights.Critical reviews in oncology/hematology2026name in abstract: DNX-2401
PMID 41705010A Decade of Oncolytic Virotherapy in Pediatric Cancers: A Systematic Review of Safety, Immune Awakening, and Emerging Efficacy.Cureus2026name in abstract: DNX-2401
PMID 41716467Potency-enhancing mutations in E3-19K and i-leader increase the cytolytic activity of the PH20/SPAM1-armed oncolytic adenovirus Ad5Δ24RGD.Molecular therapy. Oncology2026name in abstract: Ad5-Delta24RGD
PMID 41741902Clinical and translational progress in oncolytic virotherapy for pediatric CNS tumors.Journal of neuro-oncology2026name in abstract: DNX-2401
PMID 42995854MRI-Trackable Mesenchymal Stem Cells for Oncolytic Therapy: A Clinically Feasible Dual-Labeling Protocol.bioRxiv : the preprint server for biology2026name in abstract: tasadenoturev
PMID 40332328Comparison of the L3-23K and L5-Fiber Regions for Arming the Oncolytic Adenovirus Ad5-Delta-24-RGD with Reporter and Therapeutic Transgenes.International journal of molecular sciences2025name in title: Ad5-Delta24RGD
PMID 40691367Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.Nature medicine2025name in title: DNX-2401
PMID 41108331The effect of oncolytic virotherapy on pediatric brain tumor- a systematic review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2025name in abstract: DNX-2401
PMID 41228258The Emerging Role of Oncolytic Virotherapy in Glioblastoma Management.Cancers2025name in abstract: DNX-2401
PMID 41372729Emerging therapies for glioblastoma.Journal of neuro-oncology2025name in abstract: DNX-2401
PMID 41463198Oncolytic Viruses in Glioblastoma: Clinical Progress, Mechanistic Insights, and Future Therapeutic Directions.Cancers2025name in abstract: DNX-2401
PMID 38806994A viral attack on brain tumors: the potential of oncolytic virus therapy.Journal of neurovirology2024name in abstract: DNX-2401
PMID 37491263Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy.Journal of translational medicine2023name in abstract: tasadenoturev
PMID 37749907Oncolytic virotherapies for pediatric tumors.Expert opinion on biological therapy2023name in abstract: DNX-2401
PMID 34004331Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme.Seminars in cancer biology2022name in abstract: DNX-2401
PMID 35071746Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures.Molecular therapy oncolytics2022name in title: Ad5-Delta24RGD
PMID 35093451Gospel of malignant Glioma: Oncolytic virus therapy.Gene2022name in abstract: DNX-2401
PMID 35487285Clinical advances in oncolytic virotherapy for pediatric brain tumors.Pharmacology & therapeutics2022name in abstract: DNX-2401
PMID 35869159Tasadenoturev active in DIPG.Nature reviews. Clinical oncology2022name in title: tasadenoturev
PMID 33524949Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerations.Neurosurgical focus2021name in abstract: DNX-2401
PMID 33771666Oncolytic virus in gliomas: a review of human clinical investigations.Annals of oncology : official journal of the European Society for Medical Oncology2021name in abstract: DNX-2401
PMID 34373477A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation.Scientific reports2021name in title: Ad5-Delta24RGD
PMID 31726894DNX-2401: an investigational drug for the treatment of recurrent glioblastoma.Expert opinion on investigational drugs2019name in title: DNX-2401
PMID 31750274Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma.Oncolytic virotherapy2019name in abstract: DNX-2401
PMID 29475886The Oncolytic Adenovirus DNX-2401 Has Antitumor Activity in Glioblastoma.Cancer discovery2018name in title: DNX-2401
PMID 30563098Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?Cancers2018name in abstract: Ad5-Delta24RGD
PMID 18215325Intravenous administration of the conditionally replicative adenovirus Ad5-Delta24RGD induces regression of osteosarcoma lung metastases.Molecular cancer2008name in title: Ad5-Delta24RGD
PMID 17938266Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses.Molecular cancer therapeutics2007name in abstract: Ad5-Delta24RGD
PMID 16736005Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin.British journal of cancer2006name in abstract: Ad5-Delta24RGD
PMID 16948124Noninvasive imaging for evaluation of the systemic delivery of capsid-modified adenoviruses in an orthotopic model of advanced lung cancer.Cancer2006name in abstract: Ad5-Delta24RGD
PMID 14734452Conditionally replicative adenovirus with tropism expanded towards integrins inhibits osteosarcoma tumor growth in vitro and in vivo.Clinical cancer research : an official journal of the American Association for Cancer Research2004name in abstract: Ad5-Delta24RGD
PMID 15197787Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer.International journal of cancer2004name in abstract: Ad5-Delta24RGD
PMID 15493039Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy.The journal of gene medicine2004name in abstract: Ad5-Delta24RGD
PMID 15507611Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death.Journal of virology2004name in abstract: Ad5-Delta24RGD
PMID 12384532Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.Cancer research2002name in title: Ad5-Delta24RGD
Unconfirmed matches (12)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 38554031The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.Neuro-oncology2024name in title: Delta-24-RGD
PMID 33376098Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET.Clinical cancer research : an official journal of the American Association for Cancer Research2021name in title: Delta-24-RGD
PMID 34059921An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.Neuro-oncology2021name in title: Delta-24-RGD
PMID 30395338Delta-24-RGD Adenoviral Therapy Directs Oncolytic and Immune-Mediated Anti-Tumor Effects in Recurrent Malignant Glioma Patients.Neurosurgery2019name in title: Delta-24-RGD
PMID 30503830Oncolytic adenovirus Delta-24-RGD induces a widespread glioma proteotype remodeling during autophagy.Journal of proteomics2019name in title: Delta-24-RGD
PMID 31036068Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models.Acta neuropathologica communications2019name in title: Delta-24-RGD
PMID 31608328GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory.Neuro-oncology advances2019name in title: Delta-24-RGD
PMID 30123426Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection.Oncotarget2018name in title: Delta-24-RGD
PMID 28138026Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma.Molecular cancer therapeutics2017name in title: Delta-24-RGD
PMID 26661633Delta-24-RGD Induces Cytotoxicity of Glioblastoma Spheroids in Three Dimensional PEG Microwells.IEEE transactions on nanobioscience2015name in title: Delta-24-RGD
PMID 24827739Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model.PloS one2014name in title: Delta-24-RGD
PMID 18253154Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death.Molecular therapy : the journal of the American Society of Gene Therapy2008name in title: Delta-24-RGD

NIH grants

ProjectTitleOrganisationPIYearsLinked by
R44CA268421Phase 1 Study of DNX-2440 for Resectable Colorectal Liver Metastasis - IND 018569DNATRIX, INC.ROBBINS, JOAN MARIE2022–2022name in abstract: tasadenoturev
R01FD005385Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)DNATRIX, INC.LEVISETTI, MATTEO G2016–2019name in title: DNX-2401
Unconfirmed matches (1)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

ProjectTitleOrganisationPIYearsLinked by
R21CA126115Image Localization for Pathologic Correlation of Delta-24-RGDUNIVERSITY OF TX MD ANDERSON CAN CTRCONRAD, CHARLES A2007–2008name in title: Delta-24-RGD

Notes

Originated at MD Anderson as Delta-24-RGD, licensed to and renamed DNX-2401 by DNAtrix. A separate NCIt concept (C159798) covers MSC-delivered DNX-2401, which is a delivery form, not a separate construct.

How to cite

tasadenoturev (AXP000005.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000005.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.